The core business of Mediprobe Research is the conduct of Phase II-IV national and international clinical trials in the field of dermatology.

COMPANY \ History

Dr. A. Gupta is board certified dermatologist who has published over 400 publications in the field of dermatology, and in particular fungal infections. He is on the Editorial Board/ Advisory Board/ Section Editor of 20 journals and has served on the Dermatology Expert Committee of the United States Pharmacopoeia. He is the Treasurer and Board Member of the Council of Nail Disorders. Dr. Gupta is also on the Board of Directors of the Skin of Color Society.

Dr. Gupta started his medical practice in 1992 in a 1,500 sq. ft. clinic in London, Ontario. He began to consult with pharmaceutical companies in 1998 and initiated his first clinical trial in 1999. At the same time, he opened a 1,000 sq. ft. laboratory in Toronto, Canada dedicated to basic research of fungal species responsible for clinical skin diseases.

By 2000, the business of clinical research experienced strong growth that resulted in the creation of the company Mediprobe Research dedicated to Phase II-IV studies in dermatology. Rapidly, his clinical operations outgrew his small clinic and he needed to expand into larger facilities. In 2003, Dr. Gupta acquired an 18,000 sq. ft. building at 645 Windermere Road, London, which was the Ontario Music Conservatory. After extensive renovations, Mediprobe Research consolidated the medical practice, the clinical research operations of Phase II-IV trials and a new custom built 2,000 sq. ft. research laboratory and strengthened its management team in the new building in the summer of 2004.

In 2005, Mediprobe Research restructured its operations to better manage its various businesses and implemented a new strategy for its operations. Mediprobe Research continued with its core business in the management of Phase II-IV clinical trials in dermatology. The company publishes 10-15 articles annually in the field of dermatology.

A new business named Acclaim Pharma Research was created. It works closely with the laboratory associated with Mediprobe Research. The laboratory continues to expand complementing both new clinical and non-clinical projects commissioned by industries along with in-house basic research.

Acclaim Pharma Research is a contract research organization that specializes in the management of in-house clinical trials. The clinic of 90 beds will conduct a variety of clinical trials where subjects can be comfortably housed for days at a time. The new studies include bioequivalence trials with oral formulations and first-n-man studies.

In 2005, another business was formed under the name AG Pharma to make strategic alliances with pharmaceutical companies to co-develop topical and oral products leading to sales and marketing.